https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1248898/full
Frontiers | Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD...
Introduction: Dihydropyrimidine dehydrogenase (DPD), encoded by DPYD gene, is the ratelimiting enzyme responsible for fluoropyrimidine (FP) catabolism. DPYD ...
pharmacogenetic testingcancer patientsfrontiersimplementingtreated
https://pubmed.ncbi.nlm.nih.gov/37927587/
Advancing pharmacogenetic testing in a tertiary hospital: a retrospective analysis after 10 years...
The field of pharmacogenetics (PGx) holds great promise in advancing personalized medicine by adapting treatments based on individual genetic profiles. Despite...
pharmacogenetic testing
https://pubmed.ncbi.nlm.nih.gov/20582584/
Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal...
Genetic factors contribute to the phenotype of drug response, but the translation of pharmacogenetic outcomes into drug discovery, drug development or clinical...
therapeutic drug monitoringpharmacogenetic testingcomplementary tools
https://www.gsb.stanford.edu/faculty-research/publications/pharmacogenetic-testing-among-patients-mood-anxiety-disorders
Pharmacogenetic Testing Among Patients With Mood and Anxiety Disorders Is Associated With Decreased...
Naturalistic and small randomized trials have suggested that pharmacogenetic testing may improve treatment outcomes in depression, but its cost-effectiveness...
pharmacogenetic testing
https://scholars.duke.edu/publication/1165565
Scholars@Duke publication: Measuring High-Risk Patients' Preferences for Pharmacogenetic Testing to...
high risk